Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties

Author:

Pachón-Angona Irene12,Bernard Paul J.1,Simakov Alexey3ORCID,Maj Maciej4,Jozwiak Krzysztof4ORCID,Novotna Anna5,Lemke Carina5,Gütschow Michael5ORCID,Martin Helene3ORCID,Oset-Gasque María-Jesús26ORCID,Contelles José-Marco78,Ismaili Lhassane1ORCID

Affiliation:

1. Université de Franche-Comté, UMR INSERM 1322 LINC, F-25000 Besançon, France

2. Department of Biochemistry and Molecular Biology, Faculty of Pharmacy, Complutense University of Madrid, Plaza Ramón y Cajal s/n, Ciudad Universitaria, 28040 Madrid, Spain

3. Université de Franche-Comté, EFS, INSERM, UMR RIGHT, F-25000 Besançon, France

4. Department of Biopharmacy, Medical University of Lublin, ul. W. Chodzki 4a, 20-093 Lublin, Poland

5. Pharmaceutical Institut, An der Immenburg 4, D-53121 Bonn, Germany

6. Instituto Universitario de Investigación en Neuroquímica, Complutense University of Madrid, Ciudad Universitaria, 28040 Madrid, Spain

7. Laboratory of Medicinal Chemistry (IQOG, CSIC) C/Juan de la Cierva 3, 28006 Madrid, Spain

8. Center for Biomedical Network Research on Rare Diseases (CIBERER), CIBER, ISCIII, 28006 Madrid, Spain

Abstract

This work relates to the design and synthesis of a series of novel multi-target directed ligands (MTDLs), i.e., compounds 4a–l, via a convenient one-pot three-component Hantzsch reaction. This approach targeted calcium channel antagonism, antioxidant capacity, cathepsin S inhibition, and interference with Nrf2 transcriptional activation. Of these MTDLs, 4i emerged as a promising compound, demonstrating robust antioxidant activity, the ability to activate Nrf2-ARE pathways, as well as calcium channel blockade and cathepsin S inhibition. Dihydropyridine 4i represents the first example of an MTDL that combines these biological activities.

Funder

Regional Council of Franche-Comté

Publisher

MDPI AG

Reference46 articles.

1. Alzheimer’s Disease;Querfurth;N. Engl. J. Med.,2010

2. (2022, April 11). Dementia. Available online: https://www.who.int/news-room/fact-sheets/detail/dementia.

3. Have There Been Improvements in Alzheimer’s Disease Drug Discovery over the Past 5 Years?;Cacabelos;Expert Opin. Drug Discov.,2018

4. The Cholinergic Hypothesis of Geriatric Memory Dysfunction;Bartus;Science,1982

5. Neuronal Loss Correlates with but Exceeds Neurofibrillary Tangles in Alzheimer’s Disease;Hollister;Ann. Neurol.,1997

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3